Sparassis beta-glucan (SCG)
Clinical trialMechanism of Action
Research Notes
Harada et al. (2002) demonstrated that oral SCG activated peritoneal macrophages and enhanced cytotoxic T cell responses in tumor-bearing mice. A Japanese pilot clinical study by Yoshikawa et al. (2010) in gynecological cancer patients receiving chemotherapy showed that oral SCG supplementation maintained or improved NK cell activity and quality of life scores during treatment. In vitro potency comparisons consistently show SCG as more potent per weight than lentinan or maitake D-fraction in macrophage activation assays.
Found In 1 Herb
3D Molecular Structure
Sparassis beta-glucan (SCG)
Representative pattern: (C₆H₁₀O₅)ₙ
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
